Skip to main content
AAN.com

Abstract

Objective

To investigate differences in pregnancy-related and perinatal outcomes in women with multiple sclerosis (MS) compared with the general population.

Methods

We conducted a cross-sectional study including pregnancies from January 1, 1997, to December 31, 2016, to women registered in the Danish Multiple Sclerosis Registry (the study cohort). Pregnancy-related and perinatal outcomes were compared with a randomly selected subcohort of pregnancies from the general population (the comparison cohort) using logistic regression adjusted for possible confounders.

Results

In total, 2,930 pregnancies were included in the study cohort and 56,958 pregnancies in the comparison cohort. No differences were found in pregnancy-related complications (preeclampsia/gestational diabetes or placenta complications), emergency caesarean section (c-section), instrumental delivery, low Apgar score, stillbirth, preterm birth, or congenital malformations. Elective c-section (odds ratio [OR] 1.89 [95% confidence interval (CI) 1.65–2.16]), induced delivery (OR 1.15 [95% CI 1.01–1.31]), and being born small for gestational age (SGA) (OR 1.29 [95 %CI 1.04–1.60]) had a higher prevalence in the study cohort, whereas the prevalence of signs indicating asphyxia was lower in the study cohort (OR 0.87 [95% CI 0.78–0.97]) relative to the comparison cohort.

Conclusion

We found a higher prevalence of elective c-sections, induced delivery, and infants being SGA among newborns to women with MS, whereas the prevalence of asphyxia was lower in the study cohort. There were no significant differences in severe adverse perinatal outcomes when comparing women with MS and their newborns with those of the general population.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520–532.
2.
Koch-Henriksen N, Thygesen LC, Stenager E, Laursen B, Magyari M. Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women. Neurology 2018;90:1954–1963.
3.
Fong A, Chau CT, Quant C, Duffy J, Pan D, Ogunyemi DA. Multiple sclerosis in pregnancy: prevalence, sociodemographic features, and obstetrical outcomes. J Matern Neonatal Med 2018;31:382–387.
4.
Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005;65:1961–1963.
5.
Yalcin SE, Yalcin Y, Yavuz A, Akkurt MO, Sezik M. Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study. J Perinat Med 2017;45:455–460.
6.
Novo A, Castelo J, de Sousa A, et al. Pregnancy outcomes in Portuguese women with multiple sclerosis: the PREGNIMS study. Mult Scler Relat Disord 2019;28:172–176.
7.
Jesus-Ribeiro J, Correia I, Martins AI, et al. Pregnancy in multiple sclerosis: a Portuguese cohort study. Mult Scler Relat Disord 2017;17:63–68.
8.
Jalkanen A, Alanen A, Airas L. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult Scler 2010;16:950–955.
9.
Macdonald SC, McElrath TF, Hernández-Díaz S. Pregnancy outcomes in women with multiple sclerosis. Am J Epidemiol 2019;188:57–66.
10.
Goldacre A, Pakpoor J, Goldacre M. Perinatal characteristics and obstetric complications in mothers with multiple sclerosis: record-linkage study. Mult Scler Relat Disord 2017;12:4–8.
11.
Van Der Kop ML, Pearce MS, Dahlgren L, et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol 2011;70:41–50.
12.
Koch-Henriksen N, Magyari M, Laursen B. Registers of multiple sclerosis in Denmark. Acta Neurol Scand 2015;132:4–10.
13.
Allison RS, Millar JH. Prevalence of disseminated sclerosis in Northern Ireland. Ulster Med J 1954;23(suppl 2):1–27.
14.
Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–231.
15.
McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2015;28:193–205.
16.
Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014;29:541–549.
17.
Koch-Henriksen N, Magyari M, Laursen B. Registers of multiple sclerosis in Denmark. Acta Neurol Scand 2015;132:4–10.
18.
Magyari M, Koch-Henriksen N, Sørensen PS. The Danish Multiple Sclerosis Treatment Register. Clin Epidemiol 2016;8:549–552.
19.
Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015;7:449–490.
20.
Tølbøll Blenstrup L, Knudsen LB. Danish registers on aspects of reproduction. Scand J Public Health 2011;39:79–82.
21.
Bliddal M, Broe A, Pottegård A, Olsen J, Langhoff-Roos J. The Danish Medical Birth Register. Eur J Epidemiol 2018;33:27–36.
22.
Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health 2011;39:91–94.
23.
Sundhedsdatastyrelsen. esundhed.dk. 2019. Available from: end2019.esundhed.dk/sundhedsregistre/MFR/Sider/MFR06A.aspx. Accessed March 5, 2020.
24.
Sankilampi U, Hannila ML, Saari A, Gissler M, Dunkel L. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann Med 2013;45:446–454.
25.
American Academy of Pediatrics Committee on Fetus and Newborn. Use and abuse of the Apgar score. Pediatrics 1996;98:141–142.
26.
Bilsteen JF, Andresen JB, Mortensen LH, Hansen AV, Andersen AMN. Educational disparities in perinatal health in Denmark in the first decade of the 21st century: a register-based cohort study. BMJ Open 2018;8:e023531.
27.
Lean SC, Derricott H, Jones RL, Heazell AEP. Advanced maternal age and adverse pregnancy outcomes: a systematic review and meta-analysis. PLoS One 2017;12:1–15.
28.
Fitzpatrick KE, Kurinczuk JJ, Bhattacharya S, Quigley MA. Planned mode of delivery after previous cesarean section and short-term maternal and perinatal outcomes: a population-based record linkage cohort study in Scotland. PLOS Med 2019;16:e1002913.
29.
Cutland CL, Lackritz EM, Mallett-Moore T, et al. Low birth weight: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine 2017;35:6492–6500.
30.
Blencowe H, Krasevec J, de Onis M, et al. National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis. Lancet Glob Health 2019;7:e849–860.
31.
Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012;2012:985646.
32.
Burkill S, Vattulainen P, Geissbuehler Y, et al. The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis. PLoS One 2019;14:e0227120.
33.
Hellwig K, Thiel S, Meinl I, Gold R, Kümpfel T. Long-term exposure to natalizumab during pregnancy - a prospective case series from the German Multiple Sclerosis and Pregnancy Registry. ECTRIMS Online Library 2018; Abstract 204.
34.
Karlsson G, Francis G, Koren G, et al. Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology 2014;82:674–680.
35.
Karlström A, Lindgren H, Hildingsson I. Maternal and infant outcome after caesarean section without recorded medical indication: findings from a Swedish case-control study. BJOG 2013;120:479–486.
36.
Finkelsztejn A, Brooks JBB, Paschoal FM, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011;118:790–797.
37.
Hedegaard M, Lidegaard Ø, Skovlund CW, Mørch LS, Hedegaard M. Reduction in stillbirths at term after new birth induction paradigm: results of a national intervention. BMJ Open 2014;4:1–8.
38.
Ko TJ, Tsai LY, Chu LC, et al. Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study. Pediatr Neonatol 2014;55:20–27.

Information & Authors

Information

Published In

Neurology® Clinical Practice
Volume 11Number 4August 2021
Pages: 280-290

Publication History

Received: June 19, 2020
Accepted: November 4, 2020
Published online: February 3, 2021
Published in print: August 2021

Permissions

Request permissions for this article.

Disclosure

J.B. Andersen has received travel and congress participation funds from Merck. T.I. Kopp served on scientific advisory board and received speaker honoraria from Novartis. F. Sellebjerg has served on scientific advisory boards, been on the steering committees of clinical trials, served as a consultant, received support for congress participation, received speaker honoraria, or received research support for his laboratory from Biogen, Merck, Novartis, Roche, Sanofi Genzyme, and Teva. M. Magyari has served on scientific advisory board for Biogen, Sanofi, Teva, Roche, Novartis, and Merck; has received honoraria for lecturing from Biogen, Merck, Novartis, Sanofi, and Genzyme; and has received research support and support for congress participation from Biogen, Genzyme, Teva, Roche, Merck, and Novartis. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Study Funding

No targeted funding reported.

Authors

Affiliations & Disclosures

Johanna Balslev Andersen, MSc
Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Merck, funding for travel and congress participation
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Tine Iskov Kopp, MSc, PhD
Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.
Disclosure
Scientific Advisory Boards:
1.
(1) Novartis
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Finn Sellebjerg, MD, PhD, DMCs https://orcid.org/0000-0002-1333-9623
Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.
Disclosure
Scientific Advisory Boards:
1.
Participation in advisory boards for Biogen, Merck, Novartis, Roche, Sanofi Genzyme.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Travel grants or speaker honoraria from Biogen, Merck, Novartis, Roche, Sanofi Genzyme, Teva.
Editorial Boards:
1.
Section editor (immunology) for Multiple Sclerosis and Related Disorders since 2012
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Member of steering committee for clinical trials for Merck and Roche. Consulting work for Novartis.
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Research support from Biogen, Merck, Novartis, Roche, Sanofi Genzyme.
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Grant support from: Danish Multiple Sclerosis Society, the Johnsen Foundation, Foundation for Research in Neurology, the Friis Foundation.
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Melinda Magyari, MD, PhD https://orcid.org/0000-0002-0972-5222
Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.
Disclosure
Scientific Advisory Boards:
1.
(1)Biogen (2)Teva (3) Sanofi (3)Roche (4) Merck (5) Novartis (6) Alexion (7) Abbvie
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1)Biogen (2)Teva (3) Sanofi (4)Novartis (5) Almirall
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
(1) Roche (2) KORA: Det Nationale Institut for Kommuners og Regioners Analyse og Forskning (2) Department of Clinical Epidemiology Ã…rhus University
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1)Biogen (2)Teva (3) Sanofi (3)Roche (4) Merck (5) Novartis
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
The Danish Multiple Sclerosis Society Fonden for Neurologisk Forskning Direktør Ejnar Jonasson, kaldet Johnsen og Hustru’s Mindelegat Lundbeck Fonden
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Andersen [email protected]
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy, Clinical and Translational Neuroscience, 8, 3, (26), (2024).https://doi.org/10.3390/ctn8030026
    Crossref
  2. Cesarian sections in women with multiple sclerosis: A Canadian prospective pregnancy study, Multiple Sclerosis Journal - Experimental, Translational and Clinical, 10, 4, (2024).https://doi.org/10.1177/20552173241285546
    Crossref
  3. Children born preterm or small for gestational age to mothers with multiple sclerosis: Do these children have an increased risk of infections in early life?, Multiple Sclerosis Journal, 30, 9, (1176-1184), (2024).https://doi.org/10.1177/13524585241249077
    Crossref
  4. Pregnancy and reproductive health in women with multiple sclerosis: an update, Current Opinion in Neurology, 37, 3, (202-211), (2024).https://doi.org/10.1097/WCO.0000000000001275
    Crossref
  5. Patient-centered pregnancy planning in multiple sclerosis: evidence for a new era, Arquivos de Neuro-Psiquiatria, 82, 10, (001-011), (2024).https://doi.org/10.1055/s-0044-1791202
    Crossref
  6. Neonatal outcomes in women with Multiple Sclerosis – Influence of disease activity: A Danish nationwide cohort study, Multiple Sclerosis and Related Disorders, 85, (105549), (2024).https://doi.org/10.1016/j.msard.2024.105549
    Crossref
  7. Maternal Multiple Sclerosis and Health Outcomes Among the Children: A Systematic Review, Clinical Epidemiology, Volume 15, (375-389), (2023).https://doi.org/10.2147/CLEP.S392273
    Crossref
  8. Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study, Multiple Sclerosis Journal, 29, 6, (731-740), (2023).https://doi.org/10.1177/13524585231161492
    Crossref
  9. Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy, Journal of Neurology, Neurosurgery & Psychiatry, 95, 6, (561-570), (2023).https://doi.org/10.1136/jnnp-2023-332804
    Crossref
  10. Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020, Journal of Neurology, Neurosurgery & Psychiatry, 94, 9, (689-697), (2023).https://doi.org/10.1136/jnnp-2022-330883
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share